In Vivo Tracking and 3D Mapping of Cell Death in Regeneration and Cancer Using Trypan Blue

Tracking cell death in vivo can enable a better understanding of the biological mechanisms underlying tissue homeostasis and disease. Unfortunately, existing cell death labeling methods lack compatibility with in vivo applications or suffer from low sensitivity, poor tissue penetration, and limited temporal resolution. Here, we fluorescently labeled dead cells in vivo with Trypan Blue (TBlue) to detect single scattered dead cells or to generate whole-mount three-dimensional maps of large areas of necrotic tissue during organ regeneration. TBlue effectively marked different types of cell death, including necrosis induced by CCl<sub>4</sub> intoxication in the liver, necrosis caused by ischemia-reperfusion in the skin, and apoptosis triggered by <i>BAX</i> overexpression in hepatocytes. Moreover, due to its short circulating lifespan in blood, TBlue labeling allowed in vivo "pulse and chase" tracking of two temporally spaced populations of dying hepatocytes in regenerating mouse livers. Additionally, upon treatment with cisplatin, TBlue labeled dead cancer cells in livers with cholangiocarcinoma and dead thymocytes due to chemotherapy-induced toxicity, showcasing its utility in assessing anticancer therapies in preclinical models. Thus, TBlue is a sensitive and selective cell death marker for in vivo applications, facilitating the understanding of the fundamental role of cell death in normal biological processes and its implications in disease.

Authors

Institutions

Publication Details

Journal
Cells
Published
2024-08-20
DOI
https://doi.org/10.3390/cells13161379
Citations
2
Primary Topic
Nanoplatforms for cancer theranostics
Type
article
Field-Weighted Citation Impact
0.37

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

In Vivo Tracking and 3D Mapping of Cell Death in Regeneration and Cancer Using Trypan Blue

Georg Halder, Andrés Caicedo, Andrés Romero‐Carvajal, Leticia Sansores-García et al.
2 citations
Cells
Nanoplatforms for cancer theranostics
0.37
article

In Vivo Tracking and 3D Mapping of Cell Death in Regeneration and Cancer Using Trypan Blue

Georg Halder, Andrés Caicedo, Andrés Romero‐Carvajal, Leticia Sansores-García, Isabel Baroja, Iván M. Moya, Ana Cecilia Santamaría-Naranjo, Hanne Hillen, Elisabeth Verboven, Nicole Procel, Priscila A. Guerrero, Carlos Estrella-García, Nicole Vizcaino-Rodríguez, Karen Camacho
article en
2 citations

Abstract

Tracking cell death in vivo can enable a better understanding of the biological mechanisms underlying tissue homeostasis and disease. Unfortunately, existing cell death labeling methods lack compatibility with in vivo applications or suffer from low sensitivity, poor tissue penetration, and limited temporal resolution. Here, we fluorescently labeled dead cells in vivo with Trypan Blue (TBlue) to detect single scattered dead cells or to generate whole-mount three-dimensional maps of large areas of necrotic tissue during organ regeneration. TBlue effectively marked different types of cell death, including necrosis induced by CCl<sub>4</sub> intoxication in the liver, necrosis caused by ischemia-reperfusion in the skin, and apoptosis triggered by <i>BAX</i> overexpression in hepatocytes. Moreover, due to its short circulating lifespan in blood, TBlue labeling allowed in vivo "pulse and chase" tracking of two temporally spaced populations of dying hepatocytes in regenerating mouse livers. Additionally, upon treatment with cisplatin, TBlue labeled dead cancer cells in livers with cholangiocarcinoma and dead thymocytes due to chemotherapy-induced toxicity, showcasing its utility in assessing anticancer therapies in preclinical models. Thus, TBlue is a sensitive and selective cell death marker for in vivo applications, facilitating the understanding of the fundamental role of cell death in normal biological processes and its implications in disease.

CellsVol. 13(16)
Karolinska Institutet (SE), Pontificia Universidad Católica del Ecuador (EC), VIB-KU Leuven Center for Cancer Biology (BE), Universidad de Las Américas (EC), Universidad San Francisco de Quito (EC), Universidad de Extremadura (ES)
Karolinska Institutet
Good health and well-being
Openalex Percentile: Top 44%
Nanoplatforms for cancer theranostics
0.37
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.